| Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type P Vadagam, D Waters, I Lee, J Chen, D Tian, AM Near, D Lyle, ... Journal of Medical Economics 27 (1), 219-229, 2024 | | 2024 |
| PP01. 68 Real-World Treatment Patterns of Patients with EGFR Exon 20 Insertion-Mutated Advanced NSCLC Treated with Amivantamab or Mobocertinib after Platinum-Based Chemotherapy A Spira, D Waters, T Ran, P Vadagam, J He, J Vanderpoel, A Donnelly, ... Journal of Thoracic Oncology 19 (7), e32, 2024 | | 2024 |
| Disparities in lung cancer: a targeted literature review examining lung cancer screening, diagnosis, treatment, and survival outcomes in the United States LL Dwyer, P Vadagam, J Vanderpoel, C Cohen, B Lewing, J Tkacz Journal of Racial and Ethnic Health Disparities 11 (3), 1489-1500, 2024 | 6 | 2024 |
| Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation J Ken-Opurum, SSS Srinivas, S Park, S Charland, A Revel, R Preblick Journal of Comparative Effectiveness Research 12 (8), e230065, 2023 | 1 | 2023 |
| EE145 Real-World Healthcare Resource Use, Costs, and Treatment Patterns in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with Different Epidermal Growth Factor … P Vadagam, J Chen, I Lee, D Tian, DD Waters, A Near, D Lyle, ... Value in Health 26 (6), S86, 2023 | | 2023 |
| A value-based budget impact model for dronedarone compared with other rhythm control strategies J Ken-Opurum, SSS Srinivas, P Vadagam, L Faith, S Park, S Charland, ... Journal of Comparative Effectiveness Research 12 (4), e220196, 2023 | 1 | 2023 |
| EE274 Estimated Costs of Adverse Event Management in NSCLC Patients with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations Treated with Amivantamab or Mobocertinib … P Vadagam, J Vanderpoel, A Khan, M Malek, R Musci, D Zou Value in Health 25 (7), S387, 2022 | 1 | 2022 |
| EE355 The Budgetary Consequences of Increasing Utilization of Dronedarone Relative to Other Antiarrythmic Drugs to a Hypothetical US Payer J Ken-Opurum, P Vadagam, L Faith, SSS Srinivas, S Park, S Charland, ... Value in Health 25 (7), S404, 2022 | | 2022 |
| An explorative study of common themes of patient experiences with migraine E Heidari, D Rao, AR Pfalzgraf, C Lobo, V Giannetti The Primary Care Companion for CNS Disorders 24 (2), 39985, 2022 | 6 | 2022 |
| Evaluating real-world national and regional trends in definitive closure in US burn care: a survey of US burn centers JE Carter, H Amani, D Carter, KN Foster, JA Griswold, WL Hickerson, ... Journal of Burn Care & Research 43 (1), 141-148, 2022 | 16 | 2022 |
| Evaluating health economic outcomes of autologous skin cell suspension (ASCS) for definitive closure in US burn care using contemporary real-world burn center data K Foster, A Amani, D Carter, J Carter, J Griswold, B Hickerson, J Holmes, ... Journal of Current Medical Research and Opinion 4 (11), 1042-1054, 2021 | 4 | 2021 |
| 603 Evaluating real-world national and regional trends in definitive closure in US burn care: A survey of US Burn Centers JE Carter, H Amani, DW Carter, KN Foster, JA Griswold, WL Hickerson, ... Journal of Burn Care & Research 42 (Supplement_1), S153-S154, 2021 | | 2021 |
| Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis Z Hepp, SN Shah, K Smoyer, P Vadagam Journal of Managed Care & Specialty Pharmacy 27 (2), 240-255, 2021 | 29 | 2021 |
| Achados clínicos em crianças e adolescentes com fibrose cística e sua relação com variáveis socioeconômicas e moleculares PB Sanseverino | | 2020 |
| PCN203 SYSTEMATIC LITERATURE REVIEW OF TREATMENT PATTERNS OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA Z Hepp, SN Shah, P Vadagam, K Smoyer Value in Health 22, S94, 2019 | | 2019 |
| Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis (vol 24, pg 987, 2018) P Vadagam, KM Kamal, JR Covvey, V Giannetti, K Mukherjee JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY 25 (2), 285-286, 2019 | | 2019 |
| Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs V Giannetti, CF Caley, KM Kamal, JR Covvey, J McKee, BG Wells, ... International journal of clinical pharmacy 40, 1096-1105, 2018 | 51 | 2018 |
| Cost-effectiveness and budget impact of lumacaftor/ivacaftor in the treatment of cystic fibrosis P Vadagam, KM Kamal, JR Covvey, V Giannetti, K Mukherjee Journal of Managed Care & Specialty Pharmacy 24 (10), 987-997, 2018 | 10 | 2018 |
| Hospitalization costs of cystic fibrosis in the United States: a retrospective analysis P Vadagam, KM Kamal Hospital Practice 46 (4), 203-213, 2018 | 14 | 2018 |
| PATIENT PREFERENCE AND SATISFACTION WITH ORAL ONCOLYTICS: A REVIEW OF AVAILABLE INSTRUMENTS AND THEIR PSYCHOMETRIC PERFORMANCE P Vadagam, E Heidari, B Cauley, KM Kamal VALUE IN HEALTH 20 (5), A117-A117, 2017 | | 2017 |
